A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.

Tauopathies are a group of disorders leading to cognitive and behavioral impairment in the aging population. While four-repeat (4R) Tau is more abundant in corticobasal degeneration, progressive supranuclear palsy, and Alzheimer's disease, three-repeat (3R) Tau is the most abundant splice, in P...

書誌詳細
出版年:	PLoS ONE
主要な著者:	Edward Rockenstein, Cassia R Overk, Kiren Ubhi, Michael Mante, Christina Patrick, Anthony Adame, Alejandro Bisquert, Margarita Trejo-Morales, Brian Spencer, Eliezer Masliah
フォーマット:	論文
言語:	英語
出版事項:	Public Library of Science (PLoS) 2015-01-01
オンライン･アクセス:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0121570&type=printable

類似資料

Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
著者:: Edward Rockenstein, 等
出版事項: (2025-03-01)

RETRACTED ARTICLE: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
著者:: Edward Rockenstein, 等
出版事項: (2015-11-01)

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
著者:: Edward Rockenstein, 等
出版事項: (2014-07-01)

Retraction: A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.
著者:: PLOS One Editors
出版事項: (2025-01-01)

RETRACTED ARTICLE: Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 – implications for dementia with Lewy bodies
著者:: Cassia R Overk, 等
出版事項: (2014-05-01)

Retraction Note: Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5– implications for dementia with lewy bodies
著者:: Cassia R Overk, 等
出版事項: (2025-08-01)

Retraction Notice to “Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy” [Neurobiology of Disease 104 (2017) 85–96]
著者:: Omar El-Agnaf, 等
出版事項: (2025-03-01)

Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy
著者:: Janice C. Malcolm, 等
出版事項: (2019-07-01)

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
著者:: Tomas Smolek, 等
出版事項: (2019-12-01)

Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
著者:: Diana L Price, 等
出版事項: (2010-11-01)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
著者:: Tomas Smolek, 等
出版事項: (2020-02-01)

Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model
著者:: Lea Langer Horvat, 等
出版事項: (2023-03-01)

Corrigendum to “ Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy Body Disease” [Neurobiology of Disease127 (2019) 163–177]
著者:: Brian Spencer, 等
出版事項: (2024-02-01)

Tauopathy strains differentially replicate in vitro in the presence of mutant tau monomer
著者:: Christine K. Brown, 等
出版事項: (2025-10-01)

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
著者:: Isidro Ferrer, 等
出版事項: (2019-05-01)

Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice
著者:: Brian Spencer, 等
出版事項: (2025-10-01)

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy
著者:: John David Eun, 等
出版事項: (2022-07-01)

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models
著者:: Michiyo Iba, 等
出版事項: (2020-07-01)

Î±-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice
著者:: Yan-Hui Zhang, 等
出版事項: (2018-04-01)

Galectin-3 aggravates microglial activation and tau transmission in tauopathy
著者:: Jian Jing Siew, 等
出版事項: (2024-01-01)

Seeding activity of skin misfolded tau as a biomarker for tauopathies
著者:: Zerui Wang, 等
出版事項: (2024-11-01)

Tau positron emission tomography in tauopathies: A narrative review
著者:: Hyunjong Lee, 等
出版事項: (2023-03-01)

Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
著者:: Celeste Parra Bravo, 等
出版事項: (2024-06-01)

Tau protein profiling in tauopathies: a human brain study
著者:: Juan Lantero-Rodriguez, 等
出版事項: (2024-07-01)

The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition
著者:: Ghazaleh Eskandari-Sedighi, 等
出版事項: (2017-10-01)

Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease
著者:: Simona Eleuteri, 等
出版事項: (2015-02-01)

Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy
著者:: Sonia Lorena Espíndola, 等
出版事項: (2018-04-01)

Tau and tauopathies across primate species: implications for modeling neurodegenerative disorders
著者:: Julia C. Colwell, 等
出版事項: (2025-07-01)

Heterogeneous Tau Oligomers as Molecular Targets for Alzheimer’s Disease and Related Tauopathies
著者:: Chih Hung Lo
出版事項: (2022-11-01)

Self-assembly of tau fragments as a key pathologic event in tauopathies
著者:: Ly Thi Huong Luu Le, 等
出版事項: (2024-01-01)

Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
著者:: Ilaria Linda Dellarole, 等
出版事項: (2024-06-01)

Novel aspects of the phosphorylation and structure of pathological tau: implications for tauopathy biomarkers
著者:: Taeko Kimura, 等
出版事項: (2024-02-01)

RNA binding proteins co-localize with small tau inclusions in tauopathy
著者:: Brandon F. Maziuk, 等
出版事項: (2018-08-01)

Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease
著者:: Michiyo Iba, 等
出版事項: (2024-04-01)

Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
著者:: Jiqing Xu, 等
出版事項: (2016-08-01)

Author Correction: Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
著者:: Jiqing Xu, 等
出版事項: (2025-01-01)

Tauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates
著者:: Danton H. O’Day
出版事項: (2025-08-01)

PM2.5 triggers tau aggregation in a mouse model of tauopathy
著者:: Congcong Liu, 等
出版事項: (2024-07-01)

A Novel Phosphorylated Tau Conformer Implicated in the Tauopathy Pathogenesis of Human Neurons
著者:: Nahid Tofigh, 等
出版事項: (2025-04-01)

Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration
著者:: Moumita Majumder, 等
出版事項: (2024-06-01)